48 results
UPLOAD
FUSN
Fusion Pharmaceuticals Inc
4 May 20
Letter from SEC
12:00am
on page 19, please
revise the Summary to
highlight that there have been limited assessments of the long-term
safety of targeted …
alpha emitting isotope therapies in humans, and that there may be
long-term effects from
treatment with any of your future product candidates
8-K
EX-99.2
FUSN
Fusion Pharmaceuticals Inc
2 Mar 21
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
9:00am
-dosing Phase 1 ■ FPI-1966: Targeting Fibroblast Growth Factor Receptor 3 (FGFR3) ■ Recently signed long-term collaboration with AstraZeneca to develop … -1434: Recently advanced from single- to multi-dosing Phase 1 ■ FPI-1966: Targeting Fibroblast Growth Factor Receptor 3 (FGFR3) ■ Recently signed long
DRSLTR
FUSN
Fusion Pharmaceuticals Inc
14 May 20
Correspondence regarding draft registration statement
12:00am
revise the Summary to highlight that there have been limited assessments of the long-term safety of targeted alpha emitting isotope therapies … in humans, and that there may be long-term effects from treatment with any of your future product candidates. Also, revise the Summary to highlight your
8-K
EX-99.1
FUSN
Fusion Pharmaceuticals Inc
3 Jun 21
Fusion Pharmaceuticals Enters into Agreement to Build
7:30am
and supply chain infrastructure in our long-term plans, and this facility is an important milestone in executing those plans.The location
10-K/A
2023 FY
FUSN
Fusion Pharmaceuticals Inc
12 Apr 24
Annual report (amended)
8:00am
for the long-term benefit of our shareholders. We periodically review our corporate governance policies and practices and compare them to those suggested … regarding the long-term strategic goals and objectives and the quality and direction of our research and development programs;
monitoring
8-K
EX-99.1
pqcj6g05
2 Nov 20
Entry into a Material Definitive Agreement
7:11am
8-K
EX-99.1
q0jc b6i1zp
11 May 21
Fusion Pharmaceuticals Announces First Quarter 2021 Financial Results
7:45am
8-K
EX-99.1
8uqfvun5 2mu6xgua
25 Mar 21
Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results
7:46am
8-K
EX-99.1
kocdxp160e 8acm70poq
10 Nov 20
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results
7:15am
8-K
EX-99.1
kih o3pivj70jyqcv5l
17 Mar 22
Fusion Pharmaceuticals Announces Fourth Quarter
7:30am
8-K
EX-99.1
jnu 801gqf4n
9 Nov 21
Fusion Pharmaceuticals Announces Third Quarter 2021 Financial Results and Clinical Program Update
7:46am
8-K
EX-99.1
cejvbk jlcm
10 Aug 21
Fusion Pharmaceuticals Announces Second Quarter 2021 Financial Results
7:46am
DEF 14A
tkjsew
27 Apr 21
Definitive proxy
4:02pm